Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Prostatic Intraepithelial Neoplasia

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Prostatic Intraepithelial Neoplasia in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Prostatic Intraepithelial Neoplasia: A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Renner, O1
Fominaya, J1
Alonso, S1
Blanco-Aparicio, C1
Leal, JF1
Carnero, A1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Prostatic Intraepithelial Neoplasia

ArticleYear
Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.
    Carcinogenesis, 2007, Volume: 28, Issue:7

    Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Chromones; Class I Phosphatidylinositol 3-Kinases; Enzym

2007